Insight Molecular Diagnostics (IMDX) Non Operating Investment Income (2018 - 2023)
Insight Molecular Diagnostics (IMDX) posted Non Operating Investment Income of -$69000.0 for Q4 2023, up 22.47% sequentially from -$89000.0 in Q3 2023, and down 592.86% YoY from $14000.0 in Q4 2022.
Insight Molecular Diagnostics (IMDX) Non Operating Investment Income (2018 - 2023) Analysis & Trends
Insight Molecular Diagnostics has reported Non Operating Investment Income for 6 years, with the latest figure at -$69000.0 in Q4 2023.
- Quarterly Non Operating Investment Income fell 592.86% year-over-year to -$69000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$61000.0 (up 87.05% YoY) and the FY2023 annual result came in at -$61000.0, up 87.05% from the prior year.
- Non Operating Investment Income improved to -$69000.0 in Q4 2023 per IMDX's latest filing, from -$89000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $315000.0 in Q4 2020 and troughed at -$330000.0 in Q1 2022.
- A 5-year average of -$2700.0 and a median of -$21500.0 in 2021 frame the typical range for Non Operating Investment Income.
- The widest YoY moves for Non Operating Investment Income: up 981.25% in 2021, down 790.0% in 2021.
- Over 5 years, Non Operating Investment Income stood at -$36000.0 in 2019, then jumped by 975.0% to $315000.0 in 2020, then plunged by 106.03% to -$19000.0 in 2021, then surged by 173.68% to $14000.0 in 2022, then sank by 592.86% to -$69000.0 in 2023.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered -$69000.0, -$89000.0, and -$24000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -69,000.00 |
| Dec 31, 2023 | -69,000.00 |
| Sep 30, 2023 | -89,000.00 |
| Sep 30, 2023 | -89,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | -160,000.00 |
| Sep 30, 2022 | -160,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Dec 31, 2021 | -19,000.00 |
| Dec 31, 2021 | -19,000.00 |
| Sep 30, 2021 | -138,000.00 |
| Sep 30, 2021 | -138,000.00 |